MarketInOut Stock Screener Log In | Sign Up
 

bioMerieux S.A.

OTC • Healthcare • Diagnostics & Research • Quote as of 05/01/2026
bioMerieux S.A. stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeOTC
Market Capitalization9,623.88 mln
Float44.62 mln
Earnings Date02/27/2026

EPS

3.91
Solid

P / E

21.16
Premium valuation

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.88
Likely reliable

Relative Strength

5 / 100
Severely lagging

Debt / Equity

0.11
Very low leverage

Business Description

Founded in 1963 and headquartered near Lyon, France, bioMérieux is a global leader in medical diagnostics, helping clinicians and laboratories detect infectious diseases and identify harmful microorganisms quickly and accurately. The company serves both healthcare providers and industrial clients, offering a broad range of testing systems, instruments, software, and reagents used across hospitals, food production facilities, and research settings worldwide. Operating in over 160 countries, bioMérieux functions as a subsidiary of Institut Mérieux and remains focused on advancing patient care and public health through faster, more reliable diagnostic results.

Key Fundamentals

EPS3.91
P/E21.16
ROE10.10
RPS39.74
ROIC12.50
ROA7.40
Interest Cover43.77
EBITDA, mln985
EV / EBITDA9.74
EV / EBIT15.26
Revenue, mln4,730
EV / Revenue2.03

Financial Strength

Altman Z-Score4.89
Piotroski F-Score 6 / 9
Beneish M-Score-2.88
Price to Intrinsic Value1.21
Price to Graham Number1.31
Shiller PE Ratio14.18

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -19.98% 5 / 100   
1 Month -35.98% 4 / 100   
2 Months -37.19% 13 / 100   
6 Months -32.45% 18 / 100   
1 Year -20.3% 24 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us